Retatrutide Supply Register

Sources, Formats, Prices

Guide

Retatrutide Vendor Comparison: Pricing and Shipping Mechanics

Retatrutide vendor comparison: 10 mg vials work out to $10.00/mg and 20 mg vials to $9.75/mg, and flat-rate shipping widens the gap, not narrows it.

  • retatrutide
  • vendor comparison
  • pricing
  • shipping

Any retatrutide vendor comparison resolves to two numbers: cost per milligram of the vial, and how the shipping fee is divided across the milligrams in the order. Across the two catalog formats, the 20 mg vial is the cheaper unit at $195 ÷ 20 mg = $9.75/mg, against $100 ÷ 10 mg = $10.00/mg (prices as of September 2026 from the HEEZ catalog). The $0.25/mg spread is narrow on the vial alone. Shipping is what moves it, because a flat fee costs twice as much per milligram on a 10 mg order as on a 20 mg one.

What does cost per mg look like across retatrutide vial formats?

Format is the only lever that changes the base figure, and the two catalog sizes do not scale linearly.

OrderTotal mgListed price (USD)Cost per mg (USD)Arithmetic
1 × 10 mg10100.0010.000100 ÷ 10
1 × 20 mg20195.009.750195 ÷ 20
2 × 10 mg20200.0010.000200 ÷ 20
2 × 20 mg40390.009.750390 ÷ 40
4 × 10 mg40400.0010.000400 ÷ 40

Caption: retatrutide vial pricing and computed cost per mg, derived by division from listed prices as of September 2026 from the HEEZ catalog ($100 for 10 mg, $195 for 20 mg).

Two 10 mg vials and one 20 mg vial deliver the same 20 mg, but the pair costs $200 against $195, a $5 difference that spreads to $5 ÷ 20 = $0.25/mg, or 2.5% of the 10 mg figure. Any vendor comparison that stops at the sticker price misses this, because the 20 mg vial looks like the larger expense until you divide.

How much does flat-rate shipping add per milligram?

A flat fee has no relationship to the quantity it moves, so its per-mg cost falls as order size rises. Divide the fee by the milligrams in the order and the mechanic becomes visible.

OrderTotal mg$/mg added per $1.00 of flat shippingArithmetic
1 × 10 mg100.1001 ÷ 10
1 × 20 mg200.0501 ÷ 20
2 × 10 mg200.0501 ÷ 20
2 × 20 mg400.0251 ÷ 40
4 × 10 mg400.0251 ÷ 40

Caption: shipping sensitivity per dollar of flat per-order fee, computed as 1 ÷ total mg using the 10 mg and 20 mg formats in the HEEZ catalog. No shipping rate is quoted here; substitute whatever figure the listing states.

Call the flat per-order fee S. Delivered cost per mg for a 10 mg order is (100 + S) ÷ 10, and for a 20 mg order it is (195 + S) ÷ 20. Subtract the second from the first and the gap simplifies to (5 + S) ÷ 20 dollars per mg. At S = 0 that returns the $0.25/mg already computed, and every dollar of shipping adds $0.05/mg to the 20 mg vial’s advantage.

Setting the two expressions equal gives 20(100 + S) = 10(195 + S), so 2000 + 20S = 1950 + 10S, and S = −$5. There is no positive shipping fee at which the 10 mg format catches up. Shipping never rescues the smaller vial in this catalog; it only widens the spread, which is the opposite of what “free shipping over $X” thresholds train buyers to expect. Before running that math on a real listing, confirm whether the quoted price already includes shipping, because a delivered price entered as a pre-shipping price inverts the result.

Is the fee charged per order or per vial?

Per-vial fees change the arithmetic for split orders only. With a per-vial fee V, one 20 mg vial delivers at $195 + V, while two 10 mg vials deliver at $200 + 2V. The total gap becomes $5 + V rather than a flat $5, so a per-vial structure penalises format-splitting a second time.

That distinction is worth reading off the listing directly rather than inferring it from a cart total. The shipping and handling section of a listing is where the per-order or per-vial basis is normally stated, alongside cold-pack and handling surcharges that behave the same way arithmetically. Two vendors quoting identical vial prices can differ by several dollars per milligram on a single-vial order purely on this field.

Which format combination is cheapest for a fixed milligram target?

Work a 50 mg target, since neither vial size divides it cleanly. Two 20 mg vials plus one 10 mg vial gives 50 mg at (2 × $195) + $100 = $390 + $100 = $490, which is $490 ÷ 50 = $9.80/mg. Five 10 mg vials give the same 50 mg at 5 × $100 = $500, or $500 ÷ 50 = $10.00/mg. The mixed order saves $10, and it ships as three vials rather than five, which also lowers the total under a per-vial fee structure.

The rule that falls out: fill as much of the target as possible with 20 mg vials and use 10 mg vials only for the remainder. For targets that are exact multiples of 20 mg, the 10 mg format has no cost-per-mg role at all. Buyers weighing the smaller formats for a different reason should read the 5 mg and 10 mg format breakdown, since draw-count and per-vial waste arguments sit outside this arithmetic.

What trial figures should a listing be able to name?

Listings sometimes quote efficacy percentages next to a price. A number is only checkable if the listing names the trial behind it. In the phase 2 obesity trial published in the New England Journal of Medicine in 2023, 338 adults were randomly assigned to once-weekly subcutaneous retatrutide at 1 mg, 4 mg, 8 mg, or 12 mg, or to placebo, for 48 weeks, with percentage change in body weight at 24 weeks as the primary endpoint; least-squares mean change at 24 weeks was −7.2% in the 1 mg group, −17.3% in the combined 8 mg group, and −17.5% in the 12 mg group, against −1.6% for placebo (Jastreboff et al., phase 2 retatrutide obesity trial in NEJM).

Those dose arms are also what set order size. A 10 mg vial holds ten weeks of material at the 1 mg arm’s weekly amount and under one week at the 12 mg arm’s, which is why a single per-order shipping fee lands so differently on two orders of the same vial count.

A separate and much larger program is running at phase 3: TRIUMPH consists of four phase 3 multicenter randomized double-blind studies of weekly subcutaneous retatrutide against placebo in over 5,800 participants, with percent change in body weight as the weight-management primary endpoint (Giblin et al., TRIUMPH phase 3 trial design paper). Comparing a percentage from the phase 2 trial with one from a TRIUMPH readout is cross-trial arithmetic across different phases, sample sizes, and durations, not a head-to-head result, so a listing that blends the two is quoting a number no source supports.

Material sold on these listings is for research use only, and catalog arithmetic says nothing about what a given vial actually contains. Two vendors can quote an identical per-mg figure and still deliver on very different timelines, and how a listing discloses shipping origin is the field that usually accounts for it: a domestic dispatch point and a transshipped one can carry the same flat fee while running transit windows that differ by weeks.

← All articles